Clinical trial
Safety and Efficacy Comparison Of Two TAVI Systems in a Prospective Randomized Evaluation II: A Randomized, Controlled, Non-inferiority Trial Evaluating Safety and Clinical Efficacy of the Symetis ACURATE Neo Compared to the Medtronic Evolut R Bioprosthesis in Transfemoral Transcatheter Aortic Valve Implantation
NCT03192813 is registered in ClinicalTrials.gov with Ceric Sàrl as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy Comparison Of Two TAVI Systems in a Prospective Randomized Evaluation II: A Randomized, Controlled, Non-inferiority Trial Evaluating Safety and Clinical Efficacy of the Symetis ACURATE Neo Compared to the Medtronic Evolut R Bioprosthesis in Transfemoral Transcatheter Aortic Valve Implantation
- Lead sponsor
- Ceric Sàrl
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 20, 2017
- Completion date
- June 4, 2020
- Enrollment
- 796 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.